Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 10/2016

28.01.2016 | Originalien

Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis

verfasst von: PD Dr. Y. H. Lee, S.‑C. Bae

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to evaluate the relationship between the circulating serum leptin level and rheumatoid arthritis (RA) and to establish a correlation between serum leptin levels and RA activity.

Methods

We searched the PUBMED, EMBASE, and Cochrane databases. A meta-analysis was performed, comparing the serum/plasma leptin levels in patients with RA and healthy controls. Correlation coefficients between serum leptin level and either disease activity score 28 (DAS28) or C‑reactive protein (CRP) in RA patients were also examined.

Results

Thirteen studies with a total of 648 RA patients and 426 controls were included in this meta-analysis. Circulating leptin level was significantly higher in the RA group than in the control group (SMD = 1.056, 95 % CI = 0.647–1.465, p = 4.2 × 10−7). In addition, stratification by ethnicity showed a significantly elevated leptin level in the RA group in Caucasian, Turkish, and Arab populations (SMD = 0.813, 95 % CI = 0.137–1.490, p = 0.018, SMD = 0.981, 95 % CI = 0.307–1.655, p = 0.004, and SMD = 1.469, 95 % CI = 0.443–2.495, p = 0.005 respectively). A meta-analysis of correlation coefficients showed a small but significantly positive correlation between the circulating leptin level and either DAS28 (correlation coefficient = 0.275, 95 % CI = 0.076–0.452, p = 0.007) or CRP (correlation coefficient = 0.274, 95 % CI = 0.068–0.458, p = 0.010).

Conclusions

Our meta-analysis demonstrated that the circulating leptin level is significantly higher in patients with RA and that a small but significantly positive correlation exists between leptin levels and RA activity.
Literatur
1.
Zurück zum Zitat Harris ED Jr (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322(18):1277–1289CrossRefPubMed Harris ED Jr (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322(18):1277–1289CrossRefPubMed
2.
Zurück zum Zitat Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45(2):166–170CrossRef Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45(2):166–170CrossRef
3.
Zurück zum Zitat Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100CrossRefPubMedPubMedCentral Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F et al (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors 37(6):413–420CrossRefPubMed Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F et al (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors 37(6):413–420CrossRefPubMed
5.
Zurück zum Zitat Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68(4):437–446PubMed Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68(4):437–446PubMed
6.
Zurück zum Zitat Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediat Inflamm 2010:568343CrossRef Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediat Inflamm 2010:568343CrossRef
7.
Zurück zum Zitat Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA (2001) Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86(2):783–791PubMed Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA (2001) Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86(2):783–791PubMed
8.
Zurück zum Zitat Li HM, Zhang TP, Leng RX, Li XP, Li XM, Pan HF (2015) Plasma/serum leptin levels in patients with systemic lupus erythematosus: a meta-analysis. Arch Med Res 46(7):551–556CrossRefPubMed Li HM, Zhang TP, Leng RX, Li XP, Li XM, Pan HF (2015) Plasma/serum leptin levels in patients with systemic lupus erythematosus: a meta-analysis. Arch Med Res 46(7):551–556CrossRefPubMed
9.
Zurück zum Zitat Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR et al (2001) Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol 31(5):1324–1332CrossRefPubMed Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR et al (2001) Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol 31(5):1324–1332CrossRefPubMed
10.
Zurück zum Zitat Abdalla M, Effat D, Sheta M, Hamed WE (2014) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. Egypt Rheumatol 36(1):1–5CrossRef Abdalla M, Effat D, Sheta M, Hamed WE (2014) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. Egypt Rheumatol 36(1):1–5CrossRef
11.
Zurück zum Zitat Olama SM, Senna MK, Elarman M (2012) Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32(3):683–690CrossRefPubMed Olama SM, Senna MK, Elarman M (2012) Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int 32(3):683–690CrossRefPubMed
12.
Zurück zum Zitat Allam A, Radwan A (2012) The relationship of serum leptin levels with disease activity in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 34(4):185–190CrossRef Allam A, Radwan A (2012) The relationship of serum leptin levels with disease activity in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 34(4):185–190CrossRef
13.
Zurück zum Zitat Ismail F, HA-h A, Ibrahim HM (2011) Possible role of leptin, and tumor necrosis factor-alpha in hypoandrogenicity in patients with early rheumatoid arthritis. Egypt Rheumatol 33(4):209–215CrossRef Ismail F, HA-h A, Ibrahim HM (2011) Possible role of leptin, and tumor necrosis factor-alpha in hypoandrogenicity in patients with early rheumatoid arthritis. Egypt Rheumatol 33(4):209–215CrossRef
14.
Zurück zum Zitat El-Batch MM, Zakaria SS, Farouk G, El Saadany H, Selim M (2010) Changes in visfatin, adiponectin, leptin and ghrelin levels in patients with rheumatoid arthritis and their correlation with disease activity. Turkish J Biochem Biyokimya Dergisi 35(1):50–57 El-Batch MM, Zakaria SS, Farouk G, El Saadany H, Selim M (2010) Changes in visfatin, adiponectin, leptin and ghrelin levels in patients with rheumatoid arthritis and their correlation with disease activity. Turkish J Biochem Biyokimya Dergisi 35(1):50–57
15.
Zurück zum Zitat Seven A, Guzel S, Aslan M, Hamuryudan V (2009) Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int 29(7):743–747CrossRefPubMed Seven A, Guzel S, Aslan M, Hamuryudan V (2009) Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int 29(7):743–747CrossRefPubMed
16.
Zurück zum Zitat Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906–1914CrossRefPubMedPubMedCentral Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906–1914CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Turhanoğlu AD, Özmen Ş, Ogün C, Kaplan A (2009) Plasma resistin and leptin levels in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 39(3):447–451 Turhanoğlu AD, Özmen Ş, Ogün C, Kaplan A (2009) Plasma resistin and leptin levels in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 39(3):447–451
18.
Zurück zum Zitat Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27(4):335–338CrossRefPubMed Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27(4):335–338CrossRefPubMed
19.
Zurück zum Zitat Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J Birm Ala 99(10):1078CrossRef Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J Birm Ala 99(10):1078CrossRef
20.
Zurück zum Zitat Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1198–1201CrossRefPubMedPubMedCentral Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1198–1201CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195–1198CrossRefPubMedPubMedCentral Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195–1198CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(10):952–956CrossRefPubMedPubMedCentral Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(10):952–956CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37(1):227–234CrossRefPubMed Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37(1):227–234CrossRefPubMed
24.
Zurück zum Zitat Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833CrossRefPubMed Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833CrossRefPubMed
25.
Zurück zum Zitat Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19(6):703–710CrossRefPubMed Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19(6):703–710CrossRefPubMed
26.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRefPubMedPubMedCentral Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
30.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed
31.
32.
Zurück zum Zitat Aminzadeh MA, Pahl MV, Barton CH, Doctor NS, Vaziri ND (2009) Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes. Nephrol Dial Transplant 24(12):3626–3631CrossRefPubMed Aminzadeh MA, Pahl MV, Barton CH, Doctor NS, Vaziri ND (2009) Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes. Nephrol Dial Transplant 24(12):3626–3631CrossRefPubMed
33.
Zurück zum Zitat Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99(10):1078–1083CrossRefPubMed Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99(10):1078–1083CrossRefPubMed
34.
Zurück zum Zitat Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gómez-Reino J et al (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology 45(8):944–950CrossRefPubMed Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gómez-Reino J et al (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology 45(8):944–950CrossRefPubMed
36.
Zurück zum Zitat Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901CrossRefPubMed Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901CrossRefPubMed
37.
Zurück zum Zitat White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA (1997) Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 272(7):4065–4071CrossRefPubMed White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA (1997) Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 272(7):4065–4071CrossRefPubMed
38.
Zurück zum Zitat Muraoka S, Kusunoki N, Takahashi H, Tsuchiya K, Kawai S (2013) Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin Exp Rheumatol 31(4):589–595PubMed Muraoka S, Kusunoki N, Takahashi H, Tsuchiya K, Kawai S (2013) Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin Exp Rheumatol 31(4):589–595PubMed
39.
Zurück zum Zitat Alshaker H, Wang Q, Frampton AE, Krell J, Waxman J, Winkler M et al (2015) Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Res Treat 149(1):59–67CrossRefPubMed Alshaker H, Wang Q, Frampton AE, Krell J, Waxman J, Winkler M et al (2015) Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Res Treat 149(1):59–67CrossRefPubMed
41.
Zurück zum Zitat Fazeli M, Zarkesh-Esfahani H, Wu Z, Maamra M, Bidlingmaier M, Pockley AG et al (2006) Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods 312(1–2):190–200CrossRefPubMed Fazeli M, Zarkesh-Esfahani H, Wu Z, Maamra M, Bidlingmaier M, Pockley AG et al (2006) Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods 312(1–2):190–200CrossRefPubMed
42.
Zurück zum Zitat Iliopoulos D, Malizos KN, Tsezou A (2007) Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66(12):1616–1621CrossRefPubMedPubMedCentral Iliopoulos D, Malizos KN, Tsezou A (2007) Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66(12):1616–1621CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Feng GS (2006) Shp2 as a therapeutic target for leptin resistance and obesity. Expert Opin Ther Targets 10(1):135–142CrossRefPubMed Feng GS (2006) Shp2 as a therapeutic target for leptin resistance and obesity. Expert Opin Ther Targets 10(1):135–142CrossRefPubMed
44.
Zurück zum Zitat Soebiyanto RP, Sreenath SN, Qu CK, Loparo KA, Bunting KD (2007) Complex systems biology approach to understanding coordination of JAK-STAT signaling. Biosystems 90(3):830–842CrossRefPubMedPubMedCentral Soebiyanto RP, Sreenath SN, Qu CK, Loparo KA, Bunting KD (2007) Complex systems biology approach to understanding coordination of JAK-STAT signaling. Biosystems 90(3):830–842CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Toussirot É, Michel F, Binda D, Dumoulin G (2015) The role of leptin in the pathophysiology of rheumatoid arthritis. Life Sci 140:29–36CrossRefPubMed Toussirot É, Michel F, Binda D, Dumoulin G (2015) The role of leptin in the pathophysiology of rheumatoid arthritis. Life Sci 140:29–36CrossRefPubMed
Metadaten
Titel
Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis
verfasst von
PD Dr. Y. H. Lee
S.‑C. Bae
Publikationsdatum
28.01.2016
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 10/2016
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-016-0050-1

Weitere Artikel der Ausgabe 10/2016

Zeitschrift für Rheumatologie 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.